Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03906292 |
|---|---|
| Brief Title: | Frontline Asciminib Combination in Chronic Phase CML (CMLXI) |
| First Submitted : | December 14, 2018 |
| First Submitted that Met QC Criteria : | April 5, 2019 |
| First Posted : | April 8, 2019 |
| Last Update Submitted that Met QC Criteria : | January 27, 2021 |
| Last Update Posted : | January 29, 2021 |